본문 바로가기
HOME> 논문 > 논문 검색상세

논문 상세정보

Kainate 유발 간질중첩증 모델에서 topiramate가 해마 신경세포사와 glutamate 수용체 발현에 미치는 영향
The Effect of Topiramate on Hippocampal Neuronal Death and Expression of Glutamate Receptor in Kainate-induced Status Epilepticus Model

박민정    (동아대학교 의과대학 신경과학교실   ); 하세운    (동아대학교 의과대학 생리학교실   ); 배혜란    (동아대학교 의과대학 생리학교실   ); 김상호    (동아대학교 의과대학 신경과학교실  );
  • 초록

    신경흥분독성과 간질발작발현은 glutamate 수용체활성과 연관이 있다고 알려져 있다. a-amino-3-hydroxy-5-methyl-4-isoxazole-propionate (AMPA), kainate 수용체에 대한 glutamate 활성을 포함하는 다양한 기전을 가진 항전간제인 Topiramate는 신경보호작용을 가진다는 증거가 제시되어 Topiramate가 간질발작 후 해마의 glutamate 수용체 발현에 미치는 효과를 관찰하였다. 흰쥐에 kainate를 복강 내 주사하여 간질중첩증을 유발시킨 후 Topiramate를 1주일 주사하였다 Apop tag in situ detection kit를 이용하여 세포손상을 관찰한 결과 kainate 유발 간질중첩증 1주일 후 해마의 CA1, CA3에서 심각한 세포사를 보였으나, Topiramte 처리 군에서는 세포사가 현저히 감소하였다. 간질중첩증 이후 NMDA 수용체 아형 1,2a, 2b 발현이 현저히 증가했으나 Topiramate 처치에 의해 NMDA수용체의 발현에는 뚜렷한 변화가 없었다. AMPA수용체에서는 GluR1이 간질중첩증 이후 현저히 상향 조정되었고 GluR2는 현저히 하향조정 되었다 Topiramate 1주일 처리 시 간질중첩증으로 인해 변화된 CluR1과 GluR2의 발현이 역전되었다. 결론적으로 Topiramate는 간질중침증에 의한 CluR1/CluR2 발현비의 증가로 유발되는 흥분성 신경세포사를 억제시킴으로써 신경보호작용이 있는 것으로 보인다.


    Excitotoxicity and epileptogenesis have often been associated with glutamate receptor activation. Accumulating evidences indicates that topiramate (TPM), an antiepileptic drug with multiple mechanisms of action has neuroprotective activity. We explored the neuroprotective effect of TPM on the status epilepticus (SE)-induced hippocampal neuronal death. After development of SE by kainite injection (15 mg/Kg), rats were treated with TPM (10mg/kg) for 1 week. The neuronal death was detected by Apop tag in situ detection kit, and the expression levels of glutamate receptors were semi-quantitatively analyzed by immunoblot. Kainate-induced SE caused a significant neuronal death and cell loss in CAI and CA3 regions of hippocampus at 1 week. However, treatment of TPM for 1 week after SE markedly reduced hippocampal neuronal death. The expression of N-methyl-D-aspartate (NMDA) receptor subunit 1, was increased by SE, but was not affected by 1 week treatment of TPM. The expressions of NMDA receptor subunit 2a and 2b were not changed by either SE or TPM. As for ${\alpha}-amino-3-hydroxy-5-methyl-4-isoxazole-propionate$ (AMPA) glutamate receptors (GluR), kainate-induced SE markedly up-regulated GluR1 expression but down-regulated GluR2 expression, leading to increased formation of $Ca^{2+}$ permeable GluR2- lacking AMPA receptors. TPM administration for 1 week attenuated SE-induced expression of both the up-regulation of GluR1 and down-regulation of GluR2, reversing the ratio of GluR1/GluR2 to the control value. In conclusion, TPM protects neuronal cell death against glutamate induced excitotoxicity in kainate-induced SE model, supporting the potential of TPM as a neuroprotective agent.


  • 주제어

    kainate .   status epilepticus .   glutamate receptor .   neuroprotection .   topiramate.  

  • 참고문헌 (60)

    1. Amano, K., K. Hamada, K. Yagi and K. Seino. 1998. Antiepileptic effects of topiramate on amygdaloid kindling in rats. Epilepsy Res. 31, 123-128 
    2. Babb, T. L., W. R. Kupfer, J. K. Pretorius, P. H. Crandall and M. F. Levesque. 1991. Synaptic reorganization by mossy fibers in human epileptic fascia dentate. Neurosci. 42, 351-363 
    3. Ben-Ari, Y. 1985. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neurosci. 14, 375-403 
    4. Bittigau, P. and C. lkonomidou. 1997. Glutamate in neurologic diseases. J. Child. Neurol. 12, 471-485 
    5. Bliss, T. V. and G. L. Collingridge. 1993. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361, 31-39 
    6. Brandt, C., H. Potschka, W. Loscher and U. Ebert. 2003. NMDA receptor blockade after status epilepticus protects against limbic brain damage but not against epilepsy in the kainate model of temporal lobe epilepsy. Neurosci. 118, 727-740 
    7. Cavalheiro, E. A., D. A. Riche and G. Le Gal La Salle. 1982. Long-term effects of intrahippocampal kainic acid injection in rats: a method for inducing spontaneous recurrent seizure. Electroencepha Clin. Neurophysiol. 53, 581-589 
    8. Cha, B. H., D. C. Silveira, X. Liu, Y. Hu and G. L. Holmes. 2002. Effect of topiramate following recurrent and prolonged seizure during early development. Epilepsy Res. 51, 217-232 
    9. Choi, D. W. 1987. Ionic dependence of glutamate neurotoxicity. J. Neurosci. 7, 369-379 
    10. Choi, D. W. 1988. Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci. 11, 465-469 
    11. Choi, D. W. 1988. Glutamate neurotoxocity and desease of the nervous system. Neuron 1, 623-634 
    12. Chum, S. S., D. Limbrick, S. Sombati and R. J. DeLorenzo. 1995. Excitotoxic activation of the NMDA receptor results in inhibition of calcium/calmodulin kinase II activity in cultured hippocampal neuron. J. Neurosci. 15, 3200-3214 
    13. Coan, E. G., W. Saywood and G. L. Colligridge. 1987. MK801 blocks NMDA receptor mediated synaptic transmission and long term potentiation in rat hippocampal slices. Neurosci. 80, 111-114 
    14. DeLorenzo, R. J., S. Sombati and D. A. Coulter. 2000. Effects of topiramate on sustained repetitive firing and spontaneous recurrent seizure discharges in cultured hippocampal neurons. Epilepsia 41(Suppl 1), 540-544 
    15. Dodgson, S. J., R. P. Shank and B. E. Maryanoff. 2000. Topiramate as an inhibitor of carbonic anhydrase isoenzymes. Epilepsia 41(Suppl 1), 535-S39 
    16. Edmonds, H. J. Jr., Y. D. Jiang, R. Y. Zhang and R. Shank. 2001. Topiramate as a neuroprotectant in a rat model of global ischemia-induced neurodegeneration. Life Sci. 69, 2265-2277 
    17. Frank, J. 1995. Unchanged balance between levels of mRNA encoding AMP A glutamate receptor subtypes following global cerebral ischemia in the rat. Acta. Neurol. Scand. 92, 337-343 
    18. Gibbs, J. W. 3rd., S. Sombati, R. J. DeLorenzo and D. A. Coulter. 2000. Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neuron. Epilepsia 41(Suppl 1), 510-516 
    19. Gilbert, M. E. 1991. Potentiation of inhibition with perforant path kindling: an NMDA-receptor dependent process. Brain Res. 564, 109-116 
    20. Higuchi, M., F. N. Single, M. Kohler, B. Sommer, R. Spregel and P. H. Seeburg. RNA editing of AMP A receptor subunit GluR-B: a base-paired intron-exon structure determines posiion and efficiency. Cell 75, 1361-1370 
    21. lsokawa, M. and J. E. Mello. 1991. NMDA receptor-mediated excitability in dendritically deformed dentate granule cells in pilocarpine-treated rats. Neurosci. 129, 69-73 
    22. Jahromi, S. S., M. R. Pelletier, P. J. McDonald, H. Khosravani and P. J. Carlen. 2000. Antiepileptic efficacy of topiramate: assessment in two in vitro seizure models. Brain Res. 872, 20-28 
    23. Jonas, P. and N. Burnashev. 1995. Molecular mechanisms controlling calcium entry through AMP A-type glutamate receptor channels. Neuron 15, 987-990 
    24. Katzir, H., D. Mendoza and G. W. Mathern. 2000. Effect of theophylline and trimethobenzamide when given during kainate-induced status epilepticus: an improved histopathologic rat model of human hippocampal sclerosis. Epilepsia 41, 1390-1399 
    25. Lissin, D. V., R. C. Carroll, R. A. Nicoll, R. C. Malenka and M. von Zastrow. 1993. Rapid, activation-induced redistribution of ionotropic glutamate receptor in cultured hippocampal neurons. Proc. Natl. A cad. Sci. 19, 1263-1272 
    26. Loscher, W. 2002. Animal models of epilepsy for the development of antiepileptogenic disease-modifying drugs. A comparison of the pharmacology of kindling and poststatus epilepticus models of temporal lobe epilepsy. Epilepsy Res. 50, 105-123 
    27. Lothman, E. W., E. H. Bertram, J. Kapur and J. L. Stringer. 1990. Recurrent spontaneous hippocampal seizure in the rat as a chronic sequel to limbic status epilepticus. Epilepsy Res. 6, 110-11 
    28. Malenka, R. C. and R. A Nicoll. 1993. NMDA-receptor dependent synaptic plasticity: multiple forms and mechanisms. Trends Neurosci. 16, 521-527 
    29. Malinow, R, Z. F. Mainen and Y. Hayashi. 2000. LTP mechanisms: from silence to fourlane traffic. Curr. Opin. Neurobiol. 10, 352-357 
    30. Mathern, G. W., T. J. Babb, J. K. Pretorius and J. P. Leite. 1995. Reactive synaptogenesis and neuron densities for neuropeptide Y, somatostatin, and glutamate decarboxylase immunoreactivity in the epileptogenic human fascia dentate. J. Neurosci. 15, 3990-4004 
    31. Meldrum, B.S. 2000. Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J. Nutr. 130, 51007-51015 
    32. Mello, J. E., E. A. Cavalheiro, A. M. Tan, W. R. Kupfer, J. K. Pretorius, T. J. Babb and D. M. Finch. 1993. Circuit mechanisms of seizure in the pilocarpine model of chronic epilepsy: cell loss and mossy fiber sprouting. Epilepsia 34, 985-995 
    33. Niebauer, M. and M. Gruenthal. 1999. Topiramate reduces neuronal injury after experimental status epilepticus. Brain Res. 837, 263-269 
    34. Oguro, K. 1999. Knockdown of AMPA receptor GluR2 expression causes delayed neurodegeneration and increases damage by sublethal ischemia in hippocampal CA1 and CA3 neurons. J. Neurosci. 19, 9218-9227 
    35. Pellegrini-Giampietro, D. E., R. S. Zukin, M. V. Bennett, S. Cho and W. A. PulsineIli. 1992. Switch in glutamate receptor subunit gene expression in CA1 subfield of hippocampus following global ischemia in rats. Proc. Natl. Acad. Sci. 89, 10499-10503 
    36. Rice, A. C. and R. J. DeLorenzo. 1988. NMDA receptor activation during status epilepticus is required for the development of epilepsy. Brain Research 782, 240-247 
    37. Rogawski, M. A., P. S. Kurzman, S. I. Yamaguchi and H. Li. 2001. Role of AMPA and GluR5 kainate receptors in the development and expression of amygdala kindling in the mouse. Neurophannacology 40, 28-35 
    38. Rothman, S. M. 1983. Synaptic activity mediates death of hypoxic neurons. Science 220, 536-437 
    39. Sattler, R. and M. Tymianski. 2001. Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death. Mol. Neurobiol. 24, 107-129 
    40. Scannevin, R. H. and R. L. Huganir. 2000. Post-synaptic organization and regulation of excitatory synapses. Nat. Rev. Neurosci. 1, 133-141 
    41. Shank, R. P., J. F. Gardocki, A. J. Streeter and B. E. Maryanoff. 2000. An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanisms of action. Epilepsia 41(suppl 1), 53-59 
    42. Simon, R. P., J. H. Swan, T. Griffiths and B. S. Meldrum. 1984. Blockade of NMDA receptor may protect against ischemic damage in the brain. Science 226, 850-852 
    43. Skadski, S. and H. S. White. 2000. Topiramate blocks kainite-evoked cobalt influx into cultured neurons. Epilepsia 41(Suppl 1), 545-547 
    44. Sommer, B., M. Kohler, R. Sprengel and P. H. Seeburg. 1991. RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. Cell 67, 11-19 
    45. Susan, T. 2002. Herman Epilepsy after brain insult Targeting epileptogenesis. Neurology 59, 521- 526 
    46. Tauck, D. L. and J. V. Nadler. 1992. Evidence of functional mossy fiber sprouting in hippocampal formation of kainic acid treated rats. J. Neurosci. 5, 1016-1022 
    47. Turski, W. A, E. A Cavalheiro, M. Schwarz, S. J. Czuczwar, Z. Kleinrok and L. Turski. 1983. Limbic seizures produced by pilocarpine in rats: behavioral, electroencephalographic and neuropathological study. Behav. Brain Res. 9, 315-335 
    48. Tuunanen, J., K. Lukasiuk, T. Halonen and A. Pitkanen. 1999. Status epilepticus induced neuronal damage in the rat amygdaloid complex: distribution, time-course and mechanisms. Neurosci. 94, 473-495 
    49. White, H. S., S. D. Brown, J. H. Woodhead, G. A Skeen and H. H. Wolf. 2000. Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanisms. EpiIepsia 41(Suppl 1), 517-520 
    50. William, R. 2000. Garnett Clinical pharmacology of topiramate: a review. Epilepsia 41(suppl 1), 561-565 
    51. Ying, H. S. 1997. Sublethal oxygen glucose deprivation alters hippocampal neuronal AMP A receptor expression and vulnerability to kainate induced death. J. Neurosci. 17, 9536-9544 
    52. Zhang, X., A. A. Velumian, O. T. Jones and P. J. Carlen. 2000. Modulation of high voltage-activated calcium channels in dentate granule cells by topiramate. EpiIepsia 41 (Suppl 1), 552-560 
    53. Meldrum, B.S. 1986. Cell damage in epilepsy and the role of calcium in cytotoxicity. Adv. Neurol. 44, 849-855 
    54. Meldrum, B. S. 1994. The role of glutamate in epilepsy and other CNS disorders. Neurology 44, 514-523 
    55. Herrero, A. J., N. Del Olmo, J. R. Gonzalez-Escalada and J. M. Solis. 2002. Two new actions of topiramate: inhibition of depolarizing GABAA-mediated responses and activation of a potassium conductance. Neuropharmacology 42, 210-220 
    56. Covolan, L. and J. E. Mello. 2000. Temporal profile of neuronal injury following pilocarpine or kainic acid-in-duced status epilepticus. Epilepsy Res. 39, 133-152 
    57. Leite, J. P., Z. A. Bortolotto and E. A. Cavalheiro. 1990. Spontaneous recurrent seizures in rats: an experimental model of partial epilepsy. Neurosci. Biobehav. Rev. 14, 511-517 
    58. Racine, R. J. 1972. Modification of seizure activity by electrical stimulation II. Motor seizure. Electroencephalogr Clin. Neurophysiol. 32, 281-294 
    59. Sattler, R. and M. Tymianski. 2000. Molecular mechanisms of calcium-dependent excitotoxicity. Mol. Med. 78, 3-13 
    60. Tanaka, H., S. Y. Grooms, M. V. Bennett and R. S. Zukin. 2000. The AMPAR subunit GluR2: still front and centerstage. Brain Res. 886, 190-207 

 저자의 다른 논문

  • 박민정 (2)

    1. 2007 "초기 단계의 피질하 혈관성 치매와 알쯔하이머병에서 Tc-99m HMPAO SPECT 영상 소견 차이" 핵의학 분자영상 = Nuclear medicine and molecular imaging 41 (6): 530~537    
    2. 2008 "파킨슨병 환자의 뇌관류 분석" 핵의학 분자영상 = Nuclear medicine and molecular imaging 42 (1): 17~28    
  • 하세운 (2)

  • 배혜란 (10)

  • 김상호 (3)

 활용도 분석

  • 상세보기

    amChart 영역
  • 원문보기

    amChart 영역

원문보기

무료다운로드
유료다운로드

유료 다운로드의 경우 해당 사이트의 정책에 따라 신규 회원가입, 로그인, 유료 구매 등이 필요할 수 있습니다. 해당 사이트에서 발생하는 귀하의 모든 정보활동은 NDSL의 서비스 정책과 무관합니다.

원문복사신청을 하시면, 일부 해외 인쇄학술지의 경우 외국학술지지원센터(FRIC)에서
무료 원문복사 서비스를 제공합니다.

NDSL에서는 해당 원문을 복사서비스하고 있습니다. 위의 원문복사신청 또는 장바구니 담기를 통하여 원문복사서비스 이용이 가능합니다.

이 논문과 함께 출판된 논문 + 더보기